Patents by Inventor Qinglian Li

Qinglian Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Herpesvirus compositions and related methods
    Patent number: 12214035
    Abstract: The present disclosure relates to liquid and dried compositions comprising a live, attenuated or genetically modified herpesvirus and methods of preparing such compositions, in one aspect, the composition comprises at least two or more pharmaceutically acceptable excepients, at least one of which is histidine and at least one of which is a sugar or sugar alcohol. The compostions retain a sufficiently high infectious titre following storage or large-scale manufacturing steps, such as lyophilization.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: February 4, 2025
    Assignees: SANOFI PASTEUR LIMITED, SANOFI PASTEUR INC.
    Inventors: Stephen Anderson, Simon Delagrave, John Hamberger, Qinglian Li, Sophia Mundle, Nausheen Rahman
  • RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE
    Publication number: 20240398932
    Abstract: Disclosed herein are respiratory syncytial virus vaccines and methods of immunization to deliver respiratory syncytial virus vaccines in subjects.
    Type: Application
    Filed: May 10, 2024
    Publication date: December 5, 2024
    Inventors: Sebastien Carayol, William Scott Gallichan, Michael Hrynyk, Olubukola Temitope Idoko, Qinglian Li, Nausheen Rahman, Sanie Samuel Sogoyan Sesay
  • HERPESVIRUS COMPOSITIONS AND RELATED METHODS
    Publication number: 20220133881
    Abstract: The present disclosure relates to liquid and dried compositions comprising a live, attenuated or genetically modified herpesvirus and methods of preparing such compositions, in one aspect, the composition comprises at least two or more pharmaceutically acceptable excepients, at least one of which is histidine and at least one of which is a sugar or sugar alcohol. The compostions retain a sufficiently high infectious titre following storage or large-scale manufacturing steps, such as lyophilization.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: Stephen ANDERSON, Simon DELAGRAVE, John HAMBERGER, Qinglian LI, Sophia MUNDLE, Nausheen RAHMAN
  • Herpesvirus compositions and related methods
    Patent number: 11260123
    Abstract: The present disclosure relates to liquid and dried compositions comprising a live, attenuated or genetically modified herpesvirus and methods of preparing such compositions, in one aspect, the composition comprises at least two or more pharmaceutically acceptable exctpients, at least one of which is histidine and at least one of which is a sugar or sugar alcohol. The compositions retain a sufficiently high infectious titre following storage or large-scale manufacturing steps, such as lyophilization.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: March 1, 2022
    Assignees: SANOFI PASTEUR LIMITED, SANOFI PASTEUR BIOLOGICS, LLC
    Inventors: Stephen Anderson, Simon Delagrave, John Hamberger, Qinglian Li, Sophia Mundle, Nausheen Rahman
  • HERPESVIRUS COMPOSITIONS AND RELATED METHODS
    Publication number: 20150150964
    Abstract: The present disclosure relates to liquid and dried compositions comprising a live, attenuated or genetically modified herpesvirus and methods of preparing such compositions, in one aspect, the composition comprises at least two or more pharmaceutically acceptable excepients, at least one of which is histidine and at least one of which is a sugar or sugar alcohol. The compositions retain a sufficiently high infectious titre following storage or large-scale manufacturing steps, such as lyophilization.
    Type: Application
    Filed: May 21, 2013
    Publication date: June 4, 2015
    Inventors: Stephen Anderson, Simon Delagrave, John Hamberger, Qinglian Li, Sophia Mundle, Nausheen Rahman